findmyKOL

Borna Mehrad, MD

Enriched profile

Ethel Smith Research Professor and Chief, Division of Pulmonary, Critical Care and Sleep Medicine; Vice Chair of Research (UF Health pages) · University of Florida Health

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Gainesville, FL · Southeast · United StatesSpecialtyPulmonary DiseaseFocusAntifungal resistance and susceptibility+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2025–2025NIH funding2019–2026

Borna Mehrad is Ethel Smith Research Professor and Chief, Division of Pulmonary, Critical Care and Sleep Medicine; Vice Chair of Research (UF Health pages) at University of Florida Health. OpenAlex indexes 244 publications with 8,612 citations (h-index 51); ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 22 Oct 2026

Overview

Updated 22 Oct 2026

Borna Mehrad, MD, is Ethel Smith Research Professor and Chief, Division of Pulmonary, Critical Care and Sleep Medicine at University of Florida Health. The public record shows 244 publications with 8,612 citations (h-index 51), centered on Antifungal resistance and susceptibility, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Chemokine receptors and signaling. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 1 companies, 5 NIH-funded awards (2019–2026).

  • Most recent indexed publication: 2026 · Journal of magnetic resonance imaging
  • Top research focus: Antifungal resistance and susceptibility
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 1 companies

Generated from the cited public record · current as of 22 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Idiopathic Pulmonary Fibrosis1 trialLung Diseases, Interstitial1 trial

Research focus

OpenAlex concept fingerprint
Antifungal resistance and susceptibilityInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisChemokine receptors and signalingFungal and yeast genetics researchTransplantation: Methods and Outcomes

Drugs & molecules

across trials, industry payments and publications
XenonClinical trials—Industry payments8Publications—

Works with

trial sponsors and companies reporting payments
Polarean, Inc.Clinical trials—Industry payments8University of VirginiaClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
244publications

Distinct works indexed by OpenAlex, matched via ORCID; 21 in PubMed.

8,612citations

Total citations across indexed works.

51h-index

Hirsch index (OpenAlex). i10-index 101.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
1companies · 2025–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
5NIH grants · 2019–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 22 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 22 Oct 2026

1 company reported payments to CMS in program years 2025–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    38%
    Kinase inhibitor32.1%
    Ofev100%
    Part D<11 patients
    Purine Antimetabolite5.9%
    Azathioprine100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    32.9%
    Corticosteroid32.9%
    Prednisone100%
    Part D≥26 patients
  • Respiratory

    14.3%
    beta2-Adrenergic Agonist8.9%
    Albuterol Sulfate Hfa100%
    Part D<11 patients
    Corticosteroid5.5%
    Fluticasone Propionate100%
    Part D<11 patients
All 5 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)40.1% facility · 59.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 22 Oct 2026

5 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:

Publications

Updated 22 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 22 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Robert M. Strieter51Marie D. Burdick42Yogesh M. Scindia29Ellen Catherine Keeley27Reinhard Laubenbacher24Luis Sordo Vieira19Theodore J. Standiford18Mark Brantly14Yana Goddard13Kathryn R. Michels12Divya C. Patel12Ganlin Qu10Henrique AL Ribeiro9Brett A. Strieter9Bashar N Alzghoul9Matthew A Schaller9Nazli Khodayari9Arantxa V. Lazarte9Matthew Wheeler9Stacy J. Park8Christine M. Lin8Alexandra M. Bettina7Joshua J. Field7Sérgio A. Lira7Rebecca Elaine Cagnina7Tiago Machuca7Regina A. Oshins7Adam Knapp7Angelica L. Solomon7Bandita Adhikari7Zadia Dupee6Nickolas G. Diodati6Jorge E. Lascano6Carl Atkinson6Kathryn E. Barletta6Molly A. Hughes6Marie Burdick5Joel M Linden5W. J. Schroeder5Amir M. Emtiazjoo5

Online presence

Updated 22 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/borna-mehrad-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    scholars.ufl.edu/bmehrad

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.ufl.edu ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 22 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Professor and Associate Chair for Research

    University of Florida (ORCID-declared, current)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
  • Chief

    Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida (per UF Health pages)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.ufl.edu ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.